A brilliant molecule can still fail if it’s mislabeled, mishandled, or inconsistently prepared. In drug metabolism and pharmacokinetics (DMPK), compound management is the unglamorous backbone that makes exposure, clearance, and distribution data trustworthy. From the first vial received to assay-ready plates and archived residues, every step influences data integrity, turnaround time, and regulatory readiness. The following framework shows how a modern, automation-enabled workflow turns chemical inventory into decision-grade dmpk results.
Compound Management Workflow in DMPK: From Vial to Validated Data
To connect small details with big decisions, organize your workflow around these pillars.
Rigorous intake and registration.
Start by assigning a unique, searchable identity to each lot: structure, salt form, stereochemistry, CoA, hazard data, storage class, and stability notes (light, oxygen, moisture). Barcode everything and register parent/child relationships (mother stock → working aliquots). Capture concentration, solvent history, and intended use (in vitro ADME, in vivo PK, bioanalysis reference). A well-curated registry prevents mis-dose events and enables traceability during audits.
Storage that protects stability—not just space.
Match storage to the molecule: −80 °C for labile chemotypes, −20 °C for most small molecules, 2–8 °C for some peptides/oligos, desiccants or inert gas for oxidation-prone series, amber glass for photolabile scaffolds. Minimize freeze–thaw with pre-aliquoting, and apply time-out-of-freezer limits. Maintain calibrated temperature monitoring with alerts and documented excursions. Segregate “mother” vials from day-to-day working stock to reduce degradation risk across long programs.
Fit-for-purpose quality control.
Confirm identity and purity (LC-MS/UPLC, HRMS as needed), check counterion content, and verify concentration. Run quick-turn solubility/logD screens to select viable vehicles and avoid assay precipitation. For new modalities (e.g., PROTACs, oligonucleotides, ADC linkers), include adsorption and carryover checks and evaluate stability in relevant matrices. Flag out-of-trend results early so chemists can adjust synthesis or salt selection before high-throughput screening (HTS) ramps.
Automated dispensing and plate build.
Standardize dilutions and volumes with liquid-handling robots or acoustic dispensers to control CVs and eliminate pipetting bias. Normalize to common stock concentrations (e.g., 10 mM in DMSO), then create assay-ready plates with randomized layouts to reduce edge effects. Use validated plate sealing, solvent-compatible plastics, and pre-run confirmation scans. High-throughput automation platforms dramatically cut cycle time and human error—critical when supporting hundreds of ADME assays and bioanalytical standards in parallel.
Logistics and chain of custody without gaps.
Ship compounds and study samples under documented conditions (dry ice/gel packs; light-protected packaging), with labels that survive condensation and cold. Record custody hand-offs from storage to prep, to assay, to bioanalysis. For multisite programs, harmonize SDS, import permits, and controlled-substance procedures. A clean custody trail accelerates root-cause analysis if an anomalous PK profile appears.
Data systems that connect chemistry to PK.
Link the compound registry, LIMS, and ELN so every plate map, dilution factor, and storage excursion is queryable alongside PK/PD readouts. Capture instrument metadata (column ID, lot, software version) and automate audit trails (21 CFR Part 11-ready). With consistent metadata, statisticians can flag plate or lot effects, while modelers can feed accurate concentrations into population PK and PBPK models without manual reconciliation.
Governance, safety, and compliance built in.
Define SOPs for every step—intake, aliquoting, storage, plate build, disposal—and train to them. Calibrate balances, readers, and freezers on schedule. For in vivo support, align with AAALAC-accredited practices and document formulation prep (vehicle, pH, osmolality, homogeneity). Periodic audits and trend reviews keep the system healthy and inspection-ready.
Conclusion
Compound management is not clerical overhead; it’s scientific risk control. Thoughtful intake, stability-aware storage, fit-for-purpose QC, automation-driven dispensing, tight logistics, and integrated data systems cut variability and shorten cycles from synthesis to PK insight. Whether you run DMPK in-house or partner with a provider that offers high-throughput automation and cross-functional collaboration, investing in this workflow yields cleaner exposure curves, faster decisions, and fewer surprises on the path to IND and beyond.
About the Author
